Differential Expression of Tissue Inhibitor of Metalloproteinases-2 by Cutaneous Squamous and Basal Cell Carcinomas  by Wagner, Stephan N. et al.
Differential Expression of Tissue Inhibitor of
Metalloproteinases-2 by Cutaneous Squamous and
Basal Cell Carcinomas
Stephan N. Wagner,';' Hans M. Ockenfels,':' Christine Wagner,* H. Peter Soyer,t and Manfi'ed Goos*
*Department of Dermatology, University of Essen, Essen. Germany; and tDepartmenc of Den1tatolog-y, University of Graz.
Graz, Austria
Tumor cell invasion and n1.etastasis are considered to
represent a ll1.ultistep process leading to the degrada-
tion of the extracellular ll1.atrix by proteolytic en-
ZYll1.es. The functional activity of Inatrix luetallopro-
teinases (MMPs) is controlled by tissue inhibitor of
metalloproteinases-2 (TIMP-2), which has been
shown to inhibit tumor cell invasion and Inetastasis ill
vitro and ill VillO. To assess the role of TIMP-2 in
skin-derived epithelial tun1.ors, we have analyzed the
expression of TIMP-2 ll1.RNA in priInary tissue saln-
pies from human cutaneous basal (BCC) and squa-
tllOUS cell carcinoll1.a (SCC) for a correlation with
their different invasive and metastatic potential.
Comparative quantitative analysis of TIMP-2 mRNA
levels by Northern blot hybridization dell1.onstrated
T he maintenance of the structural integrity of normaltissues requires the extracellular matrix (ECM) com-ponents to be protected from proteolytic degradationby matrL"X metalloproteinases (MMPs) secreted in avariety of physiological and pathological processes
involving the skin (Liotta et "I, 1991; Pi:ilIanen et "I, 1991; Sreenath
et "I, 1992). A major mechanism of protection from proteolytic
activity of normal cell types including neutrophils, lymphocytes,
and macrophages, or invasive and metastatic tumor cells, is the
regulation of proteases by natural tight-binding protease inhibitors
known as tissue inhibitors ofmetalloproteinases (TTMPs). TIMP-2,
representing a well-characterized member of the TIMP family, has
inhibitory activity against the active forms of all the members of the
MMP family (Howard et ,,/,1991; Stetler-Stevenson d ,,/,1993) and
also tightly binds to the );ltent forms of the 72- and the 92-kDa type
IV collagenases (Goldberg er "I, 1989; Goldberg et "I, 1992; Howard
et "I, 1991). Accordingly, TIMP-2 has been shown to inhibit tumor
cell invasion and metastasis ill /Iitro and ill IliI,o (Albil1i et "I, 1991;
DeClerck ct "I, ~ 991; DeClerck et "I, 1992), as well as proliferation
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significantly higher TIMP-2 tissue levels in BCe than
in SCC, indicating an inverse correlation between
TIMP-2 expression and the ll1.etastatic capacity of
these tumors ill vilJO. By ill sitll hybridization, tUll1.or
stromal cells were identified as the principal source of
TIMP-2 ll1.RNA in both Bee and SCC. A comparable
distribution has been reported previously for several
n1.atrix Inetalloproteinases in cutaneous BCC and
SCC, indicating co-localization of ll1.etalloprotein-
ases with'their respective inhibitor. These results may
suggest that TIMP-2 substantially contributes to the
biological behavior of epitheliull1.-derived skin tumors
by significandy inhibiting tUll1.or cell metastasis. KI!)'
words: Northem IJlot hybridizatioll/in situ hylwidizatioll/illlla-
sioll//Iletastasis. ] Invest Damatol 106:321-326, 1996
of human microvascular cells, a prerequIsIte for eunlor-associated
angiogenesis (Murphy c( "I, 1993).
Several members of the MMP family have been demonstrated in
epithelium-derived skin tumors (i.e., basal cell carcinoma [BCC]
and squamous cell carcinoma [SCC]) (Karelina ct "I, 1994; Karelina
et "I, 1993; Poulsom et aI, 1993; Pyke et "I, 1992; Wagner et "I,
1992). The reponed expression pattern of these enzymes, however,
docs not sufficiently explain the different clinical behavior of these
tumors. Complete understanding of the role of MMPs in ~hese
tumors also requires the analysis of their respective inhibitors (i.e.,
quantification of their expression and identification of their cellular
origin ill IliIlO). For the present report, we quantitatively compared
the expression of TIMP-2 in primary tissue samples of human
cutaneous BCC and SCC, and identified its cellular source. The
presence ofTIMP-2 transcripts in stromal cells adjacent to invasive
tumor nodules with high expression levels in tissue samples ofBCC
and significantly lower expression levels in tissue samples of SCC
suggests t11at TIMP-2 may playa m,uor role in inhibition of ECM
degradation during invasion and metastasis of skin-derived maEg-
nant epithelial tumors.
MATERIAL AND METHODS
Material Hllman tissue samples were obtained intraoperarively. Extir-
pated samples were halved, one part being immediately frozen in liquid
nitrogen for RNA extraction and ill S;tII hybridization. The other part \vas
fixed in 10% buffered forma1.in (pH 7.0) and embedded in paraffin wax for
histological examination. Diagnosis was made illdependently by two of the
authors. According to standard histological criteria. 1~ tumors were classi-
fied as BeC (seven BCC were subtyped as nodular. five as adenoid, and rwo
as 1lI0rpheaforlll BCC) and 15 tlllllors were classified as SCC. Fifteen rissue
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sampl es representing no rmal ad ul t skin were obtained fTo m body sites at a 
d istance of at least 3 Cm to lesional skin (Table I). 
North ern blot analysis T he tulllo r mass of each frozen tissue sample 
was determined by microscopica l contro l of a representative cryostat 
section. dissected accordingly, and subjected to I~A extraction. Tota l 
cellular KNA was prepared by guanidinium thiocyan,Jte extraction and 
cesium chloride centrifi.' gation (Chirgwin ,., aI, 1979) , and the poly(A) I 
fi'action was isolated by o ligo(dT)-celllllose co lumn chromatograp hy (Phar-
macia-LKB, Freiburg, Ge rman y). Poly(A) " selected I~A samples (1U f-Lg) 
were size fractio nated on 'I 'Yu "garose, 2 M forma ldehyde gels and trans-
ferred to nylon membranes by vacu um blotting. After ultravio let cross-
linking (Stratalinker; Stratagene, Heidelberg. Germany) fi lters were hybrid-
ized to random primed [CI'-J2 PjdATI'_labe led cDNA probes and subjected to 
autoradiography as descri bed (Wagner c/ al. 1992). T he probes used 
comprised nucl eotides (iOl11 position 471-1024 of the published T IMP-2 
eD NA sequence (Stetl er-S tevenson el al. '1990) and the 3.6-kb Hind III 
fragme nt of human {3-actin sequences (p'\Hac69) (Moos and Ga ll witz, 
1983) . H ybridization was q uantifi ed by scanning autorad iographs using a 
LKB laser densitometer (Ultrascan XL, l'harmacia-LKB) and TIMP-2 
expression was corrected fo r variations in RNA loading by comparing to 
{3-actin mRNA express ion. 
III sit" hybridization C ryosections (8 f..I.m) were fix ed and hybridized as 
described (Hogan e/ (I I, 1986). Sections were incubated with the respective 
cDNA probe "S-radiolabe led to a specific activ ity of 1.8 X 10·' cpm/ f-Ll. 
Hybridi zation buffe r consisted of 50'}';, deionized formam ide, 300 rnM NaC I, 
10 mM Tris-CI. 10 mM NaPO." 5 mM ethylenediaminc tetraacetic acid. 
0 .02% Ficoll 400. 0.02% polyv in ylpyrolidonc, 0.02% bovine scrum " Ibu-
minc , 10 mg/ml yeast I~A, 'I O'X, dextran sul f.,te. and 10 111M dith iothrcito l. 
After incubation at 52°C for 12-16 h. residua l radioactive probe was 
remo ved by high stringency washing in 50%, deionized fonnamide, 300 mM 
NaCI, 10 mM T,;s-Cl, 10 mM Na PO ... 5 mM ethylenediamine tetraacetic 
ac id, and 10 111M d ithiothl'cito l at 52°C. Afte r graded de hyd ration. slides 
we re covered with LM-l autorad iographic emulsion (Amersham , Braun-
schweig, Germany) and exposed for 8 d . 
Single stranded antiscnse and sense cDNA probes were prepared essen-
tiall y as described (Schniirch and !lisau . '199 1). T hc 554-bp fragment o f 
T IMP-2 was subcloned in p13 ll1 escrip t II SIC" (Stratagene) and linea ri zed 
with X bal or Kpll I (l3oehringer, M'"lI1heim, Germany) . Sense and anti-
sense cRNA transcripts were generated by ill /li /ro transcription with T3 and 
T7 I~A pol ymerases, respectively (III /l i/ro transcription system ; Promega, 
Madison, WI). Template DNA was digcsted with RNase-free DNase 
(Boehringer) and ,:adio labelcd sense and anti-sense cD NA probes were 
synthesized by reverse tra nscription of the respective cRNA trallScript in the 
presence of [CI'- J5S ldATP. Subsequentl y, template cKNA was hydro lyzed 
'lIld labeled DNA probes were purified on Sephadex-G50 columns, precip-
itated . and disso lved in 50% deionized fo rmamide, '10 mM dithiotbre itol. 
Negative contro l was performed by hybridization with the sense cDNA 
probe. 
Statistical ana lysis Statistica l anal ysis was performed with the Man ll-
W hitney U test using the StatWorks statistica l software package (Data 
Metrics Inc .• Philadelphia , PAl . Significance was established at the leve l of 
I' < 0.05. 
R ES ULTS 
Differential TIMP-2 mRNA Expression Levels in BCC, 
SCC, and Normal Skin A ll ti ssue sa mp les ex hibited th e pre vi -
o usly reported two T IM P-2 tran scripts of 3.5 and I kg in len gth . 
T h e ra tio be twee n the two T IMP-2 tra n scripts was comparable in 
all ti ssue samples exa mine d , with a con sistentl y predominant 
expressio n of th e 3 .5-kb sp ecies (F ig 1). Quantitative e xpressio n 
ana lys is di sclosed a sig nifi cantly hig he r expl'ess io n o f T IMP-2 
mRNA in malign an t epithelial-derived skin tumo rs compared w ith 
no rm al adult skin (neC versus n orm a l: p < 0.0"01; SCC versu s 
n o rma l: p = 0.009; (Fig 1, Table I) . Hi gh est T lMP-2 mR.NA 
expression levels were observed in ncc, whereas skin-de rive d 
SCC t issu e samples exh ibi ted significantl y less T IMP-2 m l~A (p 
= 0.005; Fig 1, Table I). 
In nce , th e re was a remarkable range of sig nal inte n sities 
(0 .8-4.1 8 optica l d e n sity units) . A ltho ug h T IM P-2 mRN A expres-
sion levels in nodular nee w cre slig htly hig he r than in adcnoid 
n cc (1 .91 ::':: 1 .09 I/S 1 .70 ::':: 1.31 o ptica l de n sity uni ts), we co uld 
not demo n strate a significant corre la tion of TIMP-2 exp ress io n 
w ith histologica l sub typ es of n cc. Lowest expression levels w e re 
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F ig ure 1. Northern blot h ybridization reveals diflcrential TIMP··2 
mRNA expression ill t umor samples . n.sk, norma l skin; SCC, squa-
mous ce ll ca rcinoma; BCC. basa l ce ll carcinoma. Upper pallel, Hyb"idization 
with T IM P-2 cDNA probe.~ , T IMP-2 transcripts o f 3.5 and 1 kb in length. 
T hc migration positions o f 18S rRNA (1.86 kb) 'Illd 28S rKNA (4.71 kb) 
arc also indicated. L"II'er pallel, control of I~A load ing by reh ybridiza tioll 
with {3-actill cDNA probe. Note the increasing expression level ofTIMP-2 
mP..NA from no rmal skin to SCC to I3 CC. 
p resent in both ti ssue specime ns of the morphe a form subtype 
(1. 19 ::':: 0.56 o pti cal d e nsi ty uni ts) , h owever , suggesting an inverse 
corre lation of T I,MP-2 ex pression with th e invas ive beha vior of 
n cc subtypes. 
TIMP-2 Transcripts Are Expressed Primarily in Tumor 
Stromal Cells T issu e loca liza tion of T IMP-2 transcripts was 
p e rformed b y comparing sense an d anti-sense cD N A h yb.-idization 
patterns in section s containing n o rmal tissu e, malignant epithe lial 
tumor tissu c, and tum o r-associa ted ECM . In n ee and SCC, strong 
expressio n of T IMP-2 mRNA was o b served e xclusive ly in the 
stro mal ti ssu e w ithin o r surro unding the tumor, whereas e pithelial 
tumo r cell s th e m selves were d evoid of T IMP-2 tr an scripts (Fig 
2a, c~/;t/) . In BCC, irresp ective of th e hi sto logica l sub typ e, autora-
diograph ic sig n al for T IMP-2 II1RNA was seen predominantl y in 
th e stro mal ti ssu e immediate ly adjacen t to tUlllor cell islands (Fig 
2a,c) . Here, T IMP-2 express io n was primaril y confin ed to sp indlc-
sh aped fibrob last-like cell s and was not d ete c ted in e ndothe lial cells 
o r tulTlo r-infiltrating mononu clea r cell s at sig nifi cant levels (Fig 
2c) . In SCC, a rea c tion patte rn was o b serve d va ry in g slig h tly from 
tllat of nec. T IMP-2 I11RN A ex press io n was n ot confi n ed pre-
d o minan tly to th e strom al ce ll laye r imme diately adjacent to tumor 
ce ll n ests b u t h omogeneously distributed a ll o ver the tumor-
assoc iate d stro mal t issu e (F ig 2./) . Again , spind le-shaped cell s could 
be identified as th e major source of TIMP-2 mR.NA , w hereas 
T IMP-2 t ran scrip ts were not detec te d in endoth eli a l or infil trating 
Table I. TIMP-2 mRNA Levels Are Increased in 
Malignant Epithelial Skin Tumors 
T iss ue" II 
n cc 1<1-
Nodu!;,r 7 
Adcno id 5 
Morpheaform 2 
SCC 15 
Normal ad ul t skin 15 
(/ Bee, bas:l i l:c ll t: il n.:i II o III a; sec, sqllmno lls cell cilrci ll o lll a. 
/J OpticOl I den sity II nit's. 
Mean :!:: SD' 
1.73 :!:: 1.12 
1. 9 1 :!:: 1.09 
1.70 :!:: 1.31 
\.1 9 :!:: 0.56 
0.87 ± 0.24 
0.49 ± 0.19 
Figure 2. TIMP-2 transcripts are primarily expressed in tumor-stromal fibroblast-like cells. II/ s;(1/ hyb.idizatiol1 w ith I MP-2 anti-sense 
(a,c,eJ, II J, I,) and sense (IJ ,d,;,I) eDNA probes as indicated in Ma t",.;"ls allli Methods. Bee (II-d) , see (<'-:1) , normal adult skin (k ,i). Bee: -+ . autorndiographic 
signal fo r T IMP-2 I1lR.NA in the stro mal tiss ue adjacent to tumor ce ll islands (a). Note the background signal overlying tumor cell islands (a) compared with 
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control hybridization with sense cDNA probe (b) . Higher magnifi ca tion showing strong autoradiographic signa l in sp indle shaped fibroblast-like cells 
(~) (c), whereas epitheli al tumo r ce ll s exhibit only background labeling (c), comparab le to negative contro l (If) . No specific signal for T lMP-2 IlIR . .NA in 
vascu lar endotheli al cell s (0::» . w hereas surround ing fibrob last- li ke cells show strong hybridization reaction (~) (e). SCC: ~. strong hybridizatio n reactiOIl 
to the connective tiss ue within e pithelia l tumor cell s (j) . Again, tumor cell s themselves show only background signa l (f) comparab le to that observed b)" 
control hybrid ization with sense cD NA probe (s). Higher magnificatio n demonstrates autoradiographic signal overlying spindle shaped cell s (~) (h). 
Epithelia l tumor ce lls exh.ibit on ly background labeling (h) compared with sense hyb ridi za tion reaction (I). Tumor-infiltrating mononuclear ce lls arc devoid 
of specific autoradiographic signals for T 1MP-2 expression (0 ). whereas surrounding fibroblast-like cell s exhibi t strong hybridiza tion reaction (~) (}). Normal 
skin : ~ , spind le-shaped cell s in the pap ill ary dermis exhibiting hybrid iza tion signa l for T IMP-2 mRNA (k). Background labeling of epidermal tissue 
comparable to that observed by contro l h ybridization reactio n (I). S", /c linfs: n,bJ,g, k,1 10 I-"m; c,d,h,i 6.7 I-"m ; c,j 4 I-"m. 
mo non ucl ear cells of the tumor-associated or - surrounding ECM 
(Fig 2e,It,)). 
Dermal tissue areas at a distance from tumor cells showed a 
significant dec rease in T IMP-2 mR.NA express ion. In no nnal ad ult 
skjn , TIMP-2 mRNA was detectable at a low level, as already 
indicated by Northern blot hybridiza tion. The au toradiographic 
signal was present primarily in the dermis, again confm ed predom-
inantly to spindle-shaped cell s (Fig 21<) . 
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D ISC U SSI O N 
Tn th e presen t study, we have established that T IMP-2 is strongly 
expressed in human cu taneous BCC and SCC. Several diffe rent 
epithelium-derived human tumo r ti ssues have been described to 
express this me taUopro tein ase inhibi to r bo th at the prote in and 
messenger RN A leve l (H oyh tya ct nl, 1994; Po le tte et nl, 1993 ; 
Po ulsom el nl, 1993; Poulsom ct nl, 1992 ; Stetler-Stevenson et nl , 
1990), and o ur results indicated that cutaneous BCC and SCC also 
may be incl uded ill this spectrum of tUlll o rs. T IMP-2 transcrip ts 
appear to be local ized predominantl y to the tum o r-associated 
stromal tissue, wi th fibro blast-like ce lls as the ir principal source. 
These cells m ay represent fi broblasts as well as ti ssue macrophages, 
a cell type repo rted previo usly to express T IMP-2, fo r exampl e, in 
tlle lung (Shapiro CI aI, 1992). T hu s, the expressio n pattern of 
TlMP-2 mRNA in cutaneous BCC and SCC is com parabl e to th at 
observed in co lo rectal neoplas ia, mamm ary ca rcino m as, and head 
and n eck cancers (Polette el nl, 1993; Po ulsom et nl , 1993; Po ulsom 
et aI, 1992) . 
Proteolyti c degradation of the surro unding EC M has been im-
plicated ill the progressio n of epithelium-derived m alignant skin 
tumors (Goslen and Bauer, J 986; Kare lin a et nl, 1993; Po ulsom el (/1 , 
1993; Pyke el nl , 1992; W agner et nl , 1992; W olf et nl , 1992), and 
seve ral m embers of the MMP fa mily have been localized prirn arily 
to the ECM , with highes t expression levels in the strom al cell layer 
imm edia te ly adjacent to tumo r cell islands (Karelina ct (/1 , 1993; 
Pou lsom e/ aI, 1993; Pyke ct (/1, 1992; W agne r et (/1, 1992; W olfel 
ai, 1992) . T he expression in the 72- and 92-kDa gelatinases seem s 
to be o f particular impo rtance in BCC and SCC du e to the broad 
su bstr ate specificity of these pro teases . T he 72- kDa collagenase, 
w hich is capable of degrading basement membrane type IV collagen, 
gelatin , fib ronectin , elastin , and type V, VII , and X collagens, is 
expressed predominantly in tumor stromal fi broblasts (Poulsom et aI, 
1993; Pyke c( nl, '1992; W oessner, 1991), whereas the 92- kDa 
collagenase, which degrades type I and V gelatins, and type IV and V 
collagens (Woessner, 1991), may be present in tumor stromal m acro-
phages (Pyke ct ai , 1992) and in tumor stromal tissue-infiltra ting or 
tumor-surrounding polymo rphonuclear cells (Karelina e/ (/1 , 1994). 
O ur results in dicate co-expression of the 72- and the 92-kDa gelati-
nases w ith their Pli ncipal inhibitor T IMP-2 in the tumor-associated 
ECM of both cutaneous BCC and SCc. T he close co-localiza tion may 
consti tute an important spatial prerequisi te for the closely coordinated 
regulation of restricted and targeted proteolysis underlying the process 
of tumor ceU in vasion and metastasis, and may also help to p rotect the 
tumor basement membrane zone as well as tumor cells them selves 
from the proteolytic activity of u lmor-associated fib roblasts, tissue 
macrophages, and infiltrating polYI11 01-phonuclear cells. 
Altho ugh BCC and SCC are bo th tumors of epiderm al o rigin , 
their Inetas tatic behavior is qui te di ffe rent. BCC may show ex ten-
sive local in fi ltration bu t is extremely rarely m etastatic (Miller , 
1991), w he reas SCC has a metasta tic rate of up to 16% (D ine hart 
and Po ll ack , 1989). Derangem ent of the quantitati ve balance of 
p roteases and their inhibi to rs ei th er by overexpression of MMPs 
and/or dow nregul ation of T IMPs has been con:e1ated with the 
invasive and me tas t<ltic poten tial in several human tum o r models 
(reviewed in Stetl er-S tevenso n et (/ /, 1993) . T hu s, quanti tative 
examinatio n of T lMP-2 levels in prim ary tissue specime ns of BCC 
an d SCC may help to assess the potential ro le of this protease 
ill hibi to r ill t.um or cell in vas ion and me tastasis of epithelilll11-
derived skin tumo rs ill lIi IJo. liCC con ta ined hig h levels ofTIMP-2 
I11RN A, w hereas signifi cantly lower T IMP-2 mR.N A levels w ere 
detected in prim ary tissue specimens o f SCC. O ur results also 
indicate that the m orphcaform subtype o f I3 CC, which e xhibi ts a 
more aggressive and in vasive behavior than the nodular and 
aden oid sub types, may express lo w er lev els of T IMP-2 mR.N A 
levels, but this resul t needs to be confirmed by analysis of a larger 
Dumber o f sampl es . Nevertheless, o ur stud y prov ides evidence that 
expression ofTlMP-2 m ay be correla ted inverse ly with the invas ive 
and metastatic potential of epi thelium-derived skin tumors ill 1';1'0 . 
T IMP- J shows transuiptional regula tion of expression (Edwards l'f (/1, 
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1986; Leco e/ nl, 1992) and mRNA level of murine T lMP-2, w hich is 
highly homologous to human T lMP-2, m ay well correlate witll 
murine T IMP activity (Leco et (/1, 1992). T hus, itis likely that T [MP-2 
protein levels and/or activity may correlate wi th mRNA levels. 
T IMP-2 expressio n appears not to be restricted to tumor strom al 
ti ssue of epithelial skin tumors , but to be present in 110rmal skin as 
well. O ur data indicate that T IMP-2 expression is conJined p rimar-
ily to derm al fib roblast-like cells. T IMP-2 has been shown to be 
expressed constituti vely in norm al m ouse fibroblast cel.llines and it 
has been suggested tha t the presence ofTIMPs in no rmal fi broblas ts 
m ay represent a m ech anism fo r pro tection of the ECM against 
MMPs (Leco e( (/1 , 1992) . [n line with these inte rp reta tions, we 
speculate that tlle constitutive expressio n of T IMP- 2 tran scrip ts in 
no rmal skin m ay he lp to conserve the structural integri ty of the 
normal skin agains t the degradative attack by M MPs o f lympho-
cytes, neu trophils, and macrophages. 
T i,e nll ihors lin ' grall] 1I1 It! Dr. K.A. HIII I", II lId D r. U. IVillkl"r (Fra llcll klillik, 
Ull illersit iitsk/illik lllll Essell) for pro/! idillg tisslle specilllells , alld H. Ape! for /lis 
flss istnllCe iI/ tll(~ prt'l'arntioll of tlt e pil()/ographic work. 
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